STAT3 and neoplasm: A mouse liver metastatic tumor model showed that STAT3 inhibition enhanced the anti-tumor efficacy of CAR-T therapy by activating apoptotic signaling pathways and decreasing proliferative signaling pathways in liver-associated MDSCs (Guha et al., 2019).